Royalty Pharma to Present at Upcoming Investor Conferences
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will…
23,945€
2,24%
Echtzeit-Aktienkurs Royalty Pharma PLC
Bid:
Ask:
Nachrichten zur Royalty Pharma PLC Aktie
Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report?
Royalty Pharma (RPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023
NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will…
Ionis, Royalty Pharma Enter Into $1.1 Billion Royalty Agreement for Spinraza, Pelacarsen
Ionis, Royalty Pharma Enter Into $1.1 Billion Royalty Agreement for Spinraza, Pelacarsen...…
Ionis, Royalty Pharma ink royalty deal for up to $1.1B
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Royalty Pharma agrees to buy Ionis Pharma royalties for $1.125 bln
Royalty Pharma Plc said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis…
Form 8-K Royalty Pharma plc For: Jan 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today provided an update on…
Royalty Pharma Raises Quarterly Dividend by 5.3% >RPRX
Royalty Pharma Raises Quarterly Dividend by 5.3% >RPRX...…
Royalty Pharma raises dividend by 5.3% to $0.20
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will…